Emergent BioSolutions Inc. — Director's Dealing 2014

Dec 29, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2014-12-24

Reporting Person: Abdun-Nabi Daniel (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-12-24	Common Stock	M	5291	$18.90	Acquired	159330	Direct
2014-12-24	Commons Stock	M	6285	$15.91	Acquired	165615	Direct
2014-12-24	Common Stock	F	7236	$27.64	Disposed	158379	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-12-24	Stock Option	$18.90	M	5291	Disposed	2016-03-09	Common Stock (5291)	Direct
2014-12-24	Stock Option	$15.91	M	6285	Disposed	2017-03-08	Common Stock (6285)	Direct

Footnotes

F1: Consists of options granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan.

F2: The option vested in three equal installments in March 2010, 2011 and 2012.

F3: The option vested in three equal installments in March 2011, 2012 and 2013.